Antipsychotic treatment based on drd2 or ankk1 snp genotype

Details Antipsychotic treatment based on drd2 or ankk1 snp genotype Antipsychotic treatment based on drd2 or ankk1 snp genotype

C - Chemistry, Metallurgy

12

Q

C12Q 1/68 (2006.01)

Patent

CA 2760474

The present invention relates to the treatment of an individual with an antipsychotic based on individual's genotype at one or more single nucleotide polymorphism (SNP) associated with the dopamine receptor D2 (DRD2) and/or ankyrin repeat and kinase domain containing 1 (ANKK1 ) genes.

La présente invention porte sur le traitement d'un individu par un antipsychotique basé sur un génotype de l'individu au niveau d'un ou plusieurs polymorphismes à nucléotide unique (SNP) associés aux gènes du récepteur de la dopamine D2 (DRD2) et/ou contenant une répétition d'ankyrine et un domaine de kinase 1 (ANKK1).

Affiliated with

Also associated with

Rating

Antipsychotic treatment based on drd2 or ankk1 snp genotype does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antipsychotic treatment based on drd2 or ankk1 snp genotype, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antipsychotic treatment based on drd2 or ankk1 snp genotype will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2022213